Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling

被引:4
|
作者
Jin, Xiaorui [1 ]
Deng, Qianmei [1 ,2 ,3 ]
Ye, Shuting [1 ]
Liu, Shuting [1 ]
Fu, Yilong [4 ]
Liu, Yingfu [5 ]
Wu, Guoyang [4 ]
Ouyang, Gaoliang [1 ,2 ,3 ]
Wu, Tiantian [1 ]
机构
[1] Xiamen Univ, Fac Med & Life Sci, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen 361003, Peoples R China
[3] Xiamen Univ, Inst Hematol, Sch Med, Xiamen 361003, Peoples R China
[4] Xiamen Univ, Zhongshan Hosp, Dept Gen Surg, Xiamen 361004, Peoples R China
[5] Xiamen Univ, Sch Med, Dept Basic Med Sci, Xiamen 361102, Peoples R China
来源
THERANOSTICS | 2024年 / 14卷 / 07期
关键词
periostin; extracellular matrix; papillary thyroid tumor; cancer-associated fibroblast; IL-4; AUTOCRINE PRODUCTION; CELL-SURVIVAL; COLON-CANCER; STEM-CELLS; INTERLEUKIN-4; EXPRESSION; MICROENVIRONMENT; TUMORIGENESIS; PATHOGENESIS; PROGRESSION;
D O I
10.7150/thno.94207
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Periostin (POSTN) is a critical extracellular matrix protein in various tumor microenvironments. However, the function of POSTN in thyroid cancer progression remains largely unknown. Methods: Postn and Rag1 knock -out mice and orthotopic mouse models were used to determine the role of POSTN on papillary thyroid tumor progression. Immunofluorescence, cell co -culture, fluorescence in situ hybridization, chromatin immunoprecipitation assay, recombinant protein and inhibitor treatment were performed to explore the underlying mechanisms of POSTN-promoted papillary thyroid tumor growth. Results: POSTN is up -regulated in papillary thyroid tumors and negatively correlates with the overall survival of patients with thyroid cancer. Cancer -associated fibroblast (CAF) -derived POSTN promotes papillary thyroid tumor growth in vivo and in vitro . POSTN deficiency in CAFs significantly impairs CAF -promoted papillary thyroid tumor growth. POSTN promotes papillary thyroid tumor cell proliferation and IL -4 expression through integrin-FAK-STAT3 signaling. In turn, tumor cell -derived IL -4 induces the activation of CAFs and stimulates POSTN expression by activating STATE. We reveal the crucial role of CAF -derived POSTN and tumor cell -derived IL -4 in driving the development of papillary thyroid tumors through the POSTN-integrin-FAK-STAT3-IL-4 pathway in tumor cells and IL-4-STATE-POSTN signaling in CAFs. Conclusion: Our findings underscore the significance of POSTN and IL -4 as critical molecular mediators in the dynamic interplay between CAFs and tumor cells, ultimately supporting the growth of papillary thyroid tumors.
引用
收藏
页码:3014 / 3028
页数:15
相关论文
共 50 条
  • [41] Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7
    Ziqian Yan
    Zhimei Sheng
    Yuanhang Zheng
    Ruijun Feng
    Qinpei Xiao
    Lihong Shi
    Hongli Li
    Chonggao Yin
    Hao Luo
    Chong Hao
    Wenhao Wang
    Baogang Zhang
    Cell Death & Disease, 12
  • [42] STAT3 in cancer-associated fibroblasts promotes an immunosuppressive tumor microenvironment in PDAC.
    Lefler, Julia E.
    MarElia, Katie
    Hildreth, Blake E.
    Thies, Katie A.
    Cuitino, Maria C.
    Ostrowski, Michael C.
    CANCER RESEARCH, 2020, 80 (22)
  • [43] FAPhigh α-SMAlow cancer-associated fibroblast-derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downstream signaling pathways
    Sun, Luyao
    Ke, Miaola
    Wang, Xin
    Yin, Mengyuan
    Wei, Junni
    Xu, Lu
    Tian, Xing
    Wang, Fei
    Zhang, He
    Fu, Songbin
    Zhang, Chunyu
    MOLECULAR CARCINOGENESIS, 2022, 61 (10) : 910 - 923
  • [44] Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression
    Jiang, Yimei
    Qiu, Qingqing
    Jing, Xiaoqian
    Song, Zijia
    Zhang, Yaqi
    Wang, Changgang
    Liu, Kun
    Ye, Feng
    Ji, Xiaopin
    Luo, Fangxiu
    Zhao, Ren
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 641 : 177 - 185
  • [45] Cancer-associated fibroblast-derived exosomal miR-382-5p promotes the migration and invasion of oral squamous cell carcinoma
    Sun, Li-Ping
    Xu, Kai
    Cui, Jing
    Yuan, Dao-Ying
    Zou, Bo
    Li, Jun
    Liu, Jian-Lin
    Li, Ke-Yi
    Meng, Zhen
    Zhang, Bin
    ONCOLOGY REPORTS, 2019, 42 (04) : 1319 - 1328
  • [46] The interplay of cancer-associated fibroblasts and apoptotic cancer cells suppresses lung cancer cell growth through WISP-1-integrin ανβ3-STAT1 signaling pathway
    Kim, Shinyoung
    Yang, Kyungwon
    Kim, Kiyoon
    Kim, Hee Ja
    Kim, Da Young
    Chae, Jeesoo
    Ahn, Young-Ho
    Kang, Jihee Lee
    CELL COMMUNICATION AND SIGNALING, 2025, 23 (01)
  • [47] Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3 (vol 14, 32, 2016)
    Visavadiya, Nishant P.
    Keasey, Matthew P.
    Razskazovskiy, Vladislav
    Banerjee, Kalpita
    Jia, Cuihong
    Lovins, Chiharu
    Wright, Gary L.
    Hagg, Theo
    CELL COMMUNICATION AND SIGNALING, 2017, 15
  • [48] Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3 (vol 14, 32, 2016)
    Visavadiya, Nishant P.
    Keasey, Matthew P.
    Razskazovskiy, Vladislav
    Banerjee, Kalpita
    Jia, Cuihong
    Lovins, Chiharu
    Wright, Gary L.
    Hagg, Theo
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [49] Cancer-associated fibroblast-derived COL17A1 promotes gemcitabine resistance and tumorigenesis in pancreatic cancer cells by interacting with ACTN4
    Shi, Rongyu
    Zhang, Ning
    Li, Han
    Zhong, Hu
    Zhong, Chengcheng
    Du, Wei
    Yang, Xi
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [50] Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
    Guo, Hua
    Ha, Chunfang
    Dong, Hui
    Yang, Zhijuan
    Ma, Yuan
    Ding, Yonghui
    CANCER CELL INTERNATIONAL, 2019, 19 (01)